UK bio pharma : Innovation re invention and capital at risk
Haslam, Colin, Tsitsianis, N. and Gleadle, Pauline
(2011)
UK bio pharma : Innovation re invention and capital at risk.
UNSPECIFIED.
Institute of Chartered Accountants of Scotland.
Small and medium enterprise (SME) bio-pharmas play a significant role in the development of a knowledge-based competitive economy because they act as an incubator of creativity for the development of pharmabased products which they steer towards regulatory approval. Their contribution is predominantly the development of new pharmaceutical products which can then be licensed or sold on to big-pharma.
| Item Type | Monograph (UNSPECIFIED) |
|---|---|
| Divisions |
?? dep_afe ?? ?? ri_ssah ?? ?? rg_faru ?? ?? rc_crmes ?? ?? sbu_hbs ?? |
| Date Deposited | 18 Nov 2024 11:55 |
| Last Modified | 18 Nov 2024 11:55 |